CFG
SAGE

Citizens Financial Group’s Sage Therapeutics SAGE Stock Holding History

Citizens Financial Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-252
Closed -$10K – 802
2020
Q2 		$10K Buy
252
+195
+342% +$7.08K ﹤0.01% 779
2020
Q1 		$2K Buy
+57
New +$3.3K ﹤0.01% 1030
2019
Q4 		– Sell
-26
Closed -$4K – 1097
2019
Q3 		$4K Hold
26
– – ﹤0.01% 709
2019
Q2 		$5K Buy
+26
New +$4.44K ﹤0.01% 664

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citizens Financial Group's SAGE Position: Q3 2020 in Review

Citizens Financial Group sold out of Sage Therapeutics (SAGE) in Q3 2020, closing a stake of 252 shares — an estimated $10K sold.

Citizens Financial Group first reported a position in SAGE in Q2 2019 and held it in 4 quarters. The position peaked at $10K in Q2 2020. 230 funds tracked by Wall St. Rank hold SAGE as of Q3 2020.

  • Citizens Financial Group reported no remaining Sage Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 252 Sage Therapeutics shares in Q3 2020, an estimated $10K.
  • Citizens Financial Group first reported a position in Sage Therapeutics in Q2 2019 and held it in 4 quarters.
  • Citizens Financial Group's Sage Therapeutics position peaked at $10K in Q2 2020.
  • 230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.